Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
33.42
-1.64 (-4.68%)
Apr 29, 2026, 2:18 PM EDT - Market open
Tyra Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,988 | 1,403 | 731 | 596 | 318 | 572 | |
| Market Cap Growth | 370.42% | 91.90% | 22.61% | 87.61% | -44.42% | - | |
| Enterprise Value | 1,835 | 1,134 | 377 | 387 | 57 | 260 | |
| Last Close Price | 35.06 | 26.29 | 13.90 | 13.85 | 7.60 | 14.07 | |
| PB Ratio | 7.27 | 5.41 | 2.13 | 2.92 | 1.23 | 1.90 | |
| P/TBV Ratio | 8.05 | 5.41 | 2.13 | 2.92 | 1.23 | 1.90 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -0.96 | -0.96 | -0.98 | -0.96 | -0.96 | -1.00 | |
| Net Debt / EBITDA Ratio | 1.89 | 1.89 | 3.23 | 2.48 | 4.24 | 11.51 | |
| Net Debt / FCF Ratio | 2.63 | 2.63 | 4.76 | 3.87 | 4.89 | 12.33 | |
| Quick Ratio | 14.25 | 14.25 | 23.53 | 13.32 | 44.07 | 83.57 | |
| Current Ratio | 14.67 | 14.67 | 23.81 | 13.81 | 45.13 | 84.09 | |
| Return on Equity (ROE) | -39.83% | -39.83% | -31.60% | -29.92% | -19.77% | -16.66% | |
| Return on Assets (ROA) | -25.68% | -25.68% | -22.09% | -20.31% | -12.86% | -10.18% | |
| Return on Capital Employed (ROCE) | -50.20% | -50.20% | -29.90% | -38.00% | -22.60% | -8.70% | |
| Earnings Yield | -5.75% | -8.55% | -11.83% | -11.59% | -17.41% | -4.60% | |
| FCF Yield | -4.57% | -6.79% | -9.63% | -8.54% | -16.00% | -4.27% | |
| Buyback Yield / Dilution | -4.17% | -4.17% | -33.98% | -1.96% | -203.94% | -793.58% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.